Press Releases
24.05.2023
BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
Corporate
Show Article
08.03.2023
Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
Corporate
Show Article
27.02.2023
BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
Finance
Show Article
27.02.2023
Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
Corporate
Show Article
22.02.2023
BRAIN Biotech and TransCode Therapeutics join forces
Technology
Show Article
08.02.2023
BRAIN Biotech und AMSilk kooperieren bei der Entwicklung leistungsfähiger biobasierter Proteinfasern
Technology
Corporate
Show Article
08.02.2023
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
Technology
Show Article
16.01.2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
Finance
Show Article
10.01.2023
BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
Technology
Corporate
Show Article